Closing Bell: Fennec Pharmaceuticals Inc up on Monday (FRX)
Today in trading, shares of Fennec Pharmaceuticals Inc opened at $8.86 and closed at $9.02. Intraday prices ranged from a low of $8.65 to a high of $9.27.
Shares advanced 2.04 percent from the previous day's close of $8.84.
Today across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.
Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.
Trading volume was 3,600 on 35 total trades. On average, Fennec Pharmaceuticals Inc has traded 1,380 shares over the last 5-days and 1,830 year-to-date.
The TSX market on the whole today saw 3,734 price advancers against 1,480 declines and 101 unchanged.
During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have shrunken -19.96 percent in 52 weeks, while in 2024, they have shrunken -40.50%.
Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $241.53 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.
Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.
Currently, Fennec Pharmaceuticals Inc has an average recommendation of "Strong Buy" based on 6.00 analysts according to Zacks. Currently, there are 6 buy ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
